Advertisement | | | |
TABLE OF CONTENTS
| | | | Volume 17, Issue 3 (June 2017) | | In this issue Review Original Articles
Also new AOP | | | | | Review | Top | | Pharmacogenetics of posttransplant diabetes mellitusP Lancia, T Adam de Beaumais and E Jacqz-Aigrain Pharmacogenomics J 2017 17: 209-221; advance online publication, March 28, 2017; 10.1038/tpj.2017.1 Abstract | Full Text | | Original Articles | Top | | Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner OPENE Theusch, K Kim, K Stevens, J D Smith, Y -D I Chen, J I Rotter, D A Nickerson and M W Medina Pharmacogenomics J 2017 17: 222-229; advance online publication, March 1, 2016; 10.1038/tpj.2016.12 Abstract | Full Text | | | | Blood gene expression profiling of an early acetaminophen responseP R Bushel, R D Fannin, K Gerrish, P B Watkins and R S Paules Pharmacogenomics J 2017 17: 230-236; advance online publication, March 1, 2016; 10.1038/tpj.2016.8 Abstract | Full Text | | | | FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitorsE Mendrinou, A Patsatsi, E Zafiriou, D Papadopoulou, L Aggelou, C Sarri, Z Mamuris, A Kyriakou, D Sotiriadis, A Roussaki-Schulze, T Sarafidou and Y Vasilopoulos Pharmacogenomics J 2017 17: 237-241; advance online publication, April 5, 2016; 10.1038/tpj.2016.16 Abstract | Full Text | | | | Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspectiveP Talwar, N Kanojia, S Mahendru, R Baghel, S Grover, G Arora, G K Grewal, S Parween, A Srivastava, M Singh, S Vig, S Kushwaha, S Sharma, K Bala, Indian Genome Variation Consortium, S Kukreti and R Kukreti Pharmacogenomics J 2017 17: 242-251; advance online publication, March 8, 2016; 10.1038/tpj.2016.1 Abstract | Full Text | | | | Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancerM Gusella, S Giacopuzzi, L Bertolaso, A Zanoni, E Pezzolo, Y Modena, D Menon, P Paganin, J Weindelmayer, G Crepaldi, G De Manzoni and F Pasini Pharmacogenomics J 2017 17: 252-257; advance online publication, March 1, 2016; 10.1038/tpj.2016.9 Abstract | Full Text | | | | Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancerF Graziano, A Ruzzo, E Giacomini, T Ricciardi, G Aprile, F Loupakis, P Lorenzini, E Ongaro, F Zoratto, V Catalano, D Sarti, E Rulli, C Cremolini, M De Nictolis, G De Maglio, A Falcone, G Fiorentini and M Magnani Pharmacogenomics J 2017 17: 258-264; advance online publication, March 1, 2016; 10.1038/tpj.2016.13 Abstract | Full Text | | | | Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysisY C Yang, G C Wu, L Jin, K L Wang, Z G Bai, J Wang and Z T Zhang Pharmacogenomics J 2017 17: 265-273; advance online publication, March 22, 2016; 10.1038/tpj.2016.11 Abstract | Full Text | | | | Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemiaH Alachkar, N Fulton, B Sanford, G Malnassy, M Mutonga, R A Larson, C D Bloomfield, G Marcucci, Y Nakamura and W Stock Pharmacogenomics J 2017 17: 274-279; advance online publication, March 29, 2016; 10.1038/tpj.2016.7 Abstract | Full Text | | | | A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese populationJ Sun, M Zhu, W Shen, C Wang, J Dai, L Xu, G Jin, Z Hu, H Ma and H Shen Pharmacogenomics J 2017 17: 280-285; advance online publication, March 8, 2016; 10.1038/tpj.2016.2 Abstract | Full Text | | | | Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primaryM B Hannouf, E Winquist, S M Mahmud, M Brackstone, S Sarma, G Rodrigues, P Rogan, J S Hoch and G S Zaric Pharmacogenomics J 2017 17: 286-300; advance online publication, March 29, 2016; 10.1038/tpj.2015.94 Abstract | Full Text | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment